E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective.
McDonald, Claire, Koshi, Sharon, Busner, Lorna et al. · BMJ open · 2014 · DOI
Quick Summary
This study looked at 136 people in the UK with postural tachycardia syndrome (PoTS)—a condition where your heart rate increases too much when you stand up—and found that it causes serious tiredness and functional problems, especially in young women. The researchers compared two groups of PoTS patients and found their symptoms and quality-of-life impacts were similar to those in people with chronic fatigue syndrome (ME/CFS). Importantly, there was no consistent treatment approach across patients, with some taking no medication and others on different drug combinations.
Why It Matters
This study demonstrates that PoTS causes substantial functional impairment comparable to ME/CFS, validating the serious impact of autonomic dysfunction on quality of life. For ME/CFS researchers, it highlights the overlap in symptom burden between these conditions and underscores the need for better understanding of shared mechanisms and optimized treatment protocols for both disorders.
Observed Findings
- PoTS UK cohort was significantly younger and had fewer men than clinic-diagnosed patients (p=0.005); over 60% of PoTS patients had university or postgraduate degrees.
- PoTS UK cohort worked significantly more hours than clinic cohort (p=0.001), but time to diagnosis was significantly longer in PoTS UK patients (p=0.04).
- Despite comparable fatigue and sleepiness between PoTS and matched CFS cohorts, PoTS patients had statistically significantly higher autonomic symptom burden measured by Orthostatic Grading Scale.
- Treatment was highly variable: 21 different drug combinations were used, with β-blockers most common; approximately one-third of patients took no medication.
Inferred Conclusions
- PoTS predominantly affects young, well-educated women and causes significant, debilitating symptoms that substantially impact quality of life comparable to ME/CFS.
- The lack of treatment standardization despite consistent symptom burden suggests a need for evidence-based treatment guidelines.
- Autonomic symptom burden distinguishes PoTS from ME/CFS despite overlapping fatigue profiles, indicating distinct underlying pathophysiology.
Remaining Questions
- What are the optimal treatment protocols for PoTS, and why does treatment response vary so widely among patients?
- What are the shared and distinct biological mechanisms underlying the overlapping fatigue and functional impairment in PoTS versus ME/CFS?
What This Study Does Not Prove
This study does not establish causation or mechanisms underlying PoTS or its relationship to ME/CFS—it only documents symptom associations in two populations. The cross-sectional design cannot determine whether symptoms cause functional impairment or vice versa, nor does it evaluate treatment efficacy or identify which interventions work best for individual patients.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepOrthostatic IntoleranceFatigue
Method Flag:No ControlsMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →